21 State AGs Seek Waiver for Reproductive Telehealth Care

The federal government should let women use telehealth to access an abortion prescription drug Mifepristone during COVID-19, said Democratic attorneys general from California, 19 other states and the District of Columbia. Monday's letter urged the Department of Health and Human Services and Food and Drug Administration to waive or not enforce its risk evaluation and mitigation strategy designation. “Forcing women to unnecessarily seek in-person reproductive healthcare during this public health crisis is foolish and irresponsible,” said California's Xavier Becerra (D). HHS didn't immediately comment. The federal government is facilitating other types of telehealth (see 2003300048).